GenesisCare and Lee Health announce their efforts to transform pancreatic patient survival rates in Florida.
Fort Myers, FL, Sept. 15, 2021 – GenesisCare—one of the leading oncology providers in the United States, Australia, Spain, and the United Kingdom—is collaborating with Lee Health—one of the largest not-for-profit public health systems in Florida—to transform pancreatic patient survival rates. Today the companies announced that their collaborative Florida Center for Pancreas Diseases has been designated a Pancreatic Cancer Center of Excellence (PCCoE) by the National Pancreas Foundation (NPF).
The NPF Center designation is awarded only to institutions offering high-quality, multidisciplinary care that treat the "whole patient," focusing on the best possible outcomes and an improved quality of life.
"Our goal is to provide hope to our patients fighting this dreadful disease using the latest treatment advances available with our world-class multidisciplinary team of over 20 doctors and certified professionals," said Mark Bloomston, MD, surgical oncologist, GenesisCare, and the Founder of the Florida Pancreas Center. "Over the last six years, we have been able to leverage the resources and talent that were already present in the Ft. Myers area and recruit more experts in the field to create an outstanding team. A comprehensive and personalized approach to treating this disease is the only way to truly impact survival rates. We have to be bolder in our approach to treatment if we want to change the trajectory for our patients.” Bloomston was recruited to Southwest Florida in 2015 due to his expertise in gastrointestinal cancers, specifically pancreatic cancer.
“Receiving a cancer diagnosis of any kind is a scary life-altering experience,” said Frank Barreiro, a five-year pancreatic cancer survivor treated at the Florida Center for Pancreas Diseases. “Because of the quick efforts of Bloomston and his team, I'm here today. I'm not just living but thriving. I'm golfing, weightlifting, and fishing again. I've seen my daughter graduate high school, college and get married. I was given the gift of five more years with my high school sweetheart, my wife."
In 2021, the American Cancer Society estimates 4,700 Floridians will be diagnosed with pancreatic cancer, a challenging disease to treat because it spreads rapidly and is often found close to other organs.
Physicians at the Florida Pancreas Center treat more cases of pancreatic cancer in a single day than most oncologists see in a lifetime. Patients have access to groundbreaking new treatments before they become standard through the center's innovative clinical trial program, including oncolytic immunotherapy and irreversible electroporation. The designation as a PCCoE opens the door to new resources. One of them is an MR Linac, a technology that enables the precise targeting of pancreatic cancer cells with real-time MRI imaging to deliver more effective doses of radiation to the tumor while minimizing damage to nearby tissues.
"We now have the opportunity to further improve upon the high-quality care we are providing to hundreds of patients in our community," stated Bloomston.
"Pancreatic cancer treatment is complex, and patients want to feel confident that they are working with a highly experienced care team with the convenience of receiving that care close to home," said Dan Collins, founder and chief executive officer, GenesisCare. "Our collaboration with Lee Health brings together Florida's top pancreatic cancer specialists and the latest treatment advances to meet this need."
"The fastest way to advancing progress against cancer is through collaboration. We will continue to explore partnerships such as this to ensure that no one is left behind when it comes to receiving access to the latest medical breakthroughs and the highest possible quality of care, continued Mr. Collins."
Pancreatic cancer has the highest mortality rate of all major cancers and is the third leading cause of cancer-related deaths in the U.S., surpassed only by lung and colon cancers. Of those diagnosed this year in the U.S., an estimated 80 percent (48,000) will die from the disease.
"After more than five years of planning, we're launching a collaborative effort, dedicated to ensuring patients facing the bleakest of outcomes may benefit from a team of leading pancreatic cancer specialists," said president & chief executive officer of Lee Health Larry Antonucci, MD, MBA. "Pancreatic cancer is an aggressive and devastating disease that will continue its relentless grasp on our communities if we don't act. Now is the time for partnerships that seek to overcome obstacles, offer hope, and extend lives."
The Pancreatic Center of Excellence application requires the fulfillment of numerous criteria and dedicated core personnel and specialized physicians who lead multidisciplinary teams. There are only 62 PCCoE facilities in the U.S. This designation allows patients access to evidence-based pathways, multidisciplinary care, participation in clinical trials, ongoing investment in staff training and professional development, and ongoing audits and reviews against a range of quality metrics. The Florida Pancreas Center includes collaboration with Lee Health's Regional Cancer Center and Lee Physician Group Medical Oncology, and Florida Cancer Specialists & Research Institute. For more information on the Florida Center for Pancreas Diseases. visit https://floridapancreascenter.com/.
For more information on GenesisCare, visit genesiscare.com (formally 21st Century Oncology).
About The National Pancreas Foundation
Founded in 1997, the National Pancreas Foundation provides hope for those suffering from pancreatitis and pancreatic cancer through funding cutting-edge research, advocating for new and better therapies and providing support and education for patients, caregivers and healthcare professionals. The NPF is the only foundation dedicated to patients suffering from all forms of pancreas disease. For more information, visit www.pancreasfoundation.org.
About GenesisCare
GenesisCare is a Sydney-headquartered global healthcare company and one of the largest integrated oncology organizations. The company's mission is to design care experiences that get the best possible life outcomes. This is grounded in the belief that care should be focused on the individual, not the condition.
GenesisCare is the world's largest provider of radiotherapy – a vital treatment option for cancer patients – and provides patients with access to diagnostics, medical oncology, surgical oncology, radiotherapy, and novel therapies alongside the ability to participate in the latest clinical trials. With a growing research and trials program numbering more than 150 clinical trials, a contract research organization, and global innovation programs focused on precision medicine and novel therapies, GenesisCare aims to bring new therapies to more patients in need in a more affordable way.
Every year, GenesisCare clinical teams see more than 400,000 people at more than 440 locations. For cancer treatment, that includes more than 300 locations in the U.S., 38 locations in Australia, 14 in the UK and 21 in Spain, with more than 30 new centers under development. The organization employs more than 5,500 highly trained physicians, healthcare professionals and support staff across Australia, Europe, and now the U.S. GenesisCare also offers cardiology and sleep services at more than 80 locations across Australia.
For more information, visit genesiscare.com or visit Facebook and LinkedIn,#designingbettercare.
To view the full list of precautions GenesisCare centers are taking to ensure patient and staff safety, visit https://www.genesiscare.com/us/covid-19/.
About Lee Health
Since the opening of the first hospital in 1916, Lee Health has been a health care leader in Southwest Florida, constantly evolving to meet the needs of the community. A non-profit, integrated health care services organization, Lee Health is staffed by caring people, inspiring health, who are committed to the well-being of every individual served, focused on healthy living and maintaining good health. Services are conveniently located throughout the community in four acute care hospitals, two specialty hospitals, outpatient centers, walk-in medical centers, primary care and specialty physician practices and other services across the continuum of care. Learn more at http://www.leehealth.org/.
Ilson Examines Chemoimmunotherapy Regimens for Metastatic Gastroesophageal Cancers
December 20th 2024During a Case-Based Roundtable® event, David H. Ilson, MD, PhD, discussed the outcomes of the CheckMate 649, CheckMate 648, and KEYNOTE-859 trials of chemoimmunotherapy regimens in patients with upper GI cancers.
Read More
Tumor Treating Fields Show Significant Survival Benefit in Pancreatic Cancer
December 2nd 2024The PANOVA-3 trial demonstrated a significant 2-month overall survival improvement when adding tumor treating fields to gemcitabine and nab-paclitaxel for patients with locally advanced pancreatic adenocarcinoma.
Read More